{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:39:53Z","timestamp":1788431993972,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12866-018-1314-5","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T13:40:00Z","timestamp":1540820400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2368-8058","authenticated-orcid":false,"given":"Stephen R.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom M. A.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Staples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Lestrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gorringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"issue":"2","key":"1314_CR1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/MMBR.62.2.294-308.1998","volume":"62","author":"AR Foxwell","year":"1998","unstructured":"Foxwell AR, Kyd JM, Cripps AW. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol Mol Biol Rev. 1998;62(2):294\u2013308.","journal-title":"Microbiol Mol Biol Rev"},{"key":"1314_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2431-12-87","volume":"12","author":"RC Holder","year":"2012","unstructured":"Holder RC, Kirse DJ, Evans AK, Peters TR, Poehling KA, Swords WE, et al. One third of middle ear effusions from children undergoing tympanostomy tube placement had multiple bacterial pathogens. BMC Pediatr. BioMed Central. 2012;12:87.","journal-title":"BMC Pediatr"},{"issue":"11","key":"1314_CR3","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1128\/IAI.57.11.3555-3559.1989","volume":"57","author":"H Faden","year":"1989","unstructured":"Faden H, Brodsky L, Bernstein J, Stanievich J, Krystofik D, Shuff C, et al. Otitis media in children: local immune response to nontypeable Haemophilus influenzae. Infect Immun. 1989;57(11):3555\u20139.","journal-title":"Infect Immun"},{"issue":"1","key":"1314_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/INF.0b013e318184dba2","volume":"28","author":"TF Murphy","year":"2009","unstructured":"Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J. 2009;28(1):43\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"1314_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/COPD.S15417","volume":"6","author":"SJ Moghaddam","year":"2011","unstructured":"Moghaddam SJ, Ochoa CE, Sethi S, Dickey BF. Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer. Int J Chron Obstruct Pulmon Dis. 2011;6:113\u201323.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1314_CR6","unstructured":"Cartwright S 2012. An evaluation of screening for COPD against the National Screening Committee criteria. < https:\/\/legacyscreening.phe.org.uk\/policydb_download.php?doc=360 >. Accessed 15 Dec 2017."},{"issue":"2","key":"1314_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MCP.0000000000000023","volume":"20","author":"MM Alikhan","year":"2014","unstructured":"Alikhan MM, FE-H L. Understanding nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2014;20(2):159\u201364.","journal-title":"Curr Opin Pulm Med"},{"issue":"10","key":"1314_CR8","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3201\/eid2110.150004","volume":"21","author":"JD Langereis","year":"2015","unstructured":"Langereis JD, De Jonge MI. Invasive disease caused by nontypeable Haemophilus influenzae. Emerg Infect Dis. 2015;21(10):1711\u20138.","journal-title":"Emerg Infect Dis"},{"key":"1314_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1128\/CVI.00089-15","volume":"22","author":"TF Murphy","year":"2015","unstructured":"Murphy TF. Vaccines for nontypeable Haemophilus influenzae: the future is now. Clin Vaccine Immunol. 2015;22:459\u201366 American Society for Microbiology.","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl 1","key":"1314_CR10","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1016\/S0264-410X(00)00288-7","volume":"19","author":"JT Poolman","year":"2000","unstructured":"Poolman JT, Bakaletz L, Cripps A, Denoel PA, Forsgren A, Kyd J, et al. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine. 2000;19(Suppl 1):S108\u201315.","journal-title":"Vaccine"},{"issue":"6","key":"1314_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1586\/14760584.4.6.843","volume":"4","author":"TF Murphy","year":"2005","unstructured":"Murphy TF. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Expert Rev Vaccines. 2005;4(6):843\u201353.","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"1314_CR12","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1586\/erv.09.113","volume":"8","author":"R Prymula","year":"2009","unstructured":"Prymula R, Schuerman L. 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix\u2122. Expert Rev Vaccines. 2009;8(11):1479\u2013500.","journal-title":"Expert Rev Vaccines"},{"issue":"9512","key":"1314_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","volume":"367","author":"R Prymula","year":"2006","unstructured":"Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367(9512):740\u20138.","journal-title":"Lancet"},{"issue":"42","key":"1314_CR14","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1016\/j.vaccine.2009.07.070","volume":"27","author":"L Schuerman","year":"2009","unstructured":"Schuerman L, Borys D, Hoet B, Forsgren A, Prymula R. Prevention of otitis media: now a reality? Vaccine. 2009;27(42):5748\u201354.","journal-title":"Vaccine"},{"issue":"7","key":"1314_CR15","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/14760584.2017.1333905","volume":"16","author":"C Clarke","year":"2017","unstructured":"Clarke C, Bakaletz LO, Ruiz-Gui\u00f1az\u00fa J, Borys D, Mrkvan T. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage. Expert Rev Vaccines. Taylor & Francis. 2017;16(7):751\u201364.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"1314_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12866-015-0420-x","volume":"15","author":"G Ercoli","year":"2015","unstructured":"Ercoli G, Baddal B, Alessandra G, Marchi S, Petracca R, Aric\u00f2 B, et al. Development of a serological assay to predict antibody bactericidal activity against non-typeable Haemophilus influenzae. BMC Microbiol. 2015;15(1):87.","journal-title":"BMC Microbiol"},{"issue":"20","key":"1314_CR17","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.vaccine.2014.02.082","volume":"32","author":"F Jalalvand","year":"2014","unstructured":"Jalalvand F, Littorin N, Su Y-C, Riesbeck K. Impact of immunization with Protein F on pulmonary clearance of nontypeable Haemophilus influenzae. Vaccine Elsevier Ltd. 2014;32(20):2261\u20134.","journal-title":"Vaccine"},{"issue":"43","key":"1314_CR18","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1016\/j.vaccine.2014.08.010","volume":"32","author":"K Townsend","year":"2014","unstructured":"Townsend K, Ladhani SN, Findlow H, Borrow R. Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection. Vaccine. Elsevier. 2014;32(43):5650\u20136.","journal-title":"Vaccine"},{"issue":"21","key":"1314_CR19","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.vaccine.2004.12.014","volume":"23","author":"TF Murphy","year":"2005","unstructured":"Murphy TF, Bakaletz LO, Kyd JM, Watson B, Klein DL. Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine. 2005;23(21):2696\u2013702.","journal-title":"Vaccine"},{"issue":"5","key":"1314_CR20","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/infdis\/jit238","volume":"208","author":"PL Winokur","year":"2013","unstructured":"Winokur PL, Chaloner K, Doern GV, Ferreira J, Apicella MA. Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae. J Infect Dis. Oxford University Press. 2013;208(5):728\u201338.","journal-title":"J Infect Dis"},{"issue":"5","key":"1314_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1203\/PDR.0b013e3181b4f8a6","volume":"66","author":"A Sabirov","year":"2009","unstructured":"Sabirov A, Casey JR, Murphy TF, Pichichero ME. Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6. Pediatr Res. NIH Public Access. 2009;66(5):565\u201370.","journal-title":"Pediatr Res"},{"issue":"6","key":"1314_CR22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/infdis\/160.6.999","volume":"160","author":"H Faden","year":"1989","unstructured":"Faden H, Bernstein J, Brodsky L, Stanievich J, Krystofik D, Shuff C, et al. Otitis media in children. I. The systemic immune response to nontypable Hemophilus influenzae. J Infect Dis. 1989;160(6):999\u20131004.","journal-title":"J Infect Dis"},{"issue":"1","key":"1314_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-5876(92)90074-Y","volume":"23","author":"JM Bernstein","year":"1992","unstructured":"Bernstein JM, Faden HS, Loos BG, Murphy TF, Ogra PL. Recurrent otitis media with non-typable Haemophilus influenzae: the role of serum bactericidal antibody. Int J Pediatr Otorhinolaryngol. 1992;23(1):1\u201313.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"1\u20132","key":"1314_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jim.2013.02.007","volume":"391","author":"C Brookes","year":"2013","unstructured":"Brookes C, Kuisma E, Alexander F, Allen L, Tipton T, Ram S, et al. Development of a large scale human complement source for use in bacterial immunoassays. J Immunol Methods. Elsevier B.V. 2013;391(1\u20132):39\u201349.","journal-title":"J Immunol Methods"},{"issue":"5","key":"1314_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/CVI.00100-15","volume":"22","author":"HE Humphries","year":"2015","unstructured":"Humphries HE, Brookes C, Allen L, Kuisma E, Gorringe A, Taylor S. Seroprevalence of antibody-mediated, complement-dependent opsonophagocytic activity against Neisseria meningitidis serogroup B in England. Clin Vaccine Immunol American Society for Microbiology (ASM). 2015;22(5):503\u20139.","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"1314_CR26","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1128\/IAI.00466-06","volume":"74","author":"J Findlow","year":"2006","unstructured":"Findlow J, Taylor S, Aase A, Horton R, Heyderman R, Southern J, et al. Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac. Infect Immun. 2006;74(8):4557\u201365.","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"1314_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0022-1759(98)00136-7","volume":"219","author":"MP Richardson","year":"1998","unstructured":"Richardson MP, Ayliffe MJ, Helbert M, Davies EG. A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: comparison with the quantitative nitrobluetetrazolium test. J Immunol Methods. 1998;219(1\u20132):187\u201393.","journal-title":"J Immunol Methods"},{"issue":"2","key":"1314_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0022-1759(93)90391-J","volume":"162","author":"JA Smith","year":"1993","unstructured":"Smith JA, Weidemann MJ. Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods. 1993;162(2):261\u20138.","journal-title":"J Immunol Methods"},{"issue":"11","key":"1314_CR29","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/00007890-199512000-00017","volume":"60","author":"SA Rollins","year":"1995","unstructured":"Rollins SA, Matis LA, Springhorn JP, Setter E, Wolff DW. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs. Transplantation. 1995;60(11):1284\u201392.","journal-title":"Transplantation"},{"issue":"7","key":"1314_CR30","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.vaccine.2011.12.066","volume":"30","author":"A Martino","year":"2012","unstructured":"Martino A, Magagnoli C, De Conciliis G, D\u2019Ascenzi S, Forster MJ, Allen L, et al. Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: an investigational vaccine component against Neisseria meningitidis. Vaccine. Elsevier Ltd. 2012;30(7):1330\u201342.","journal-title":"Vaccine"},{"key":"1314_CR31","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1172\/JCI118195","volume":"96","author":"CS Rinder","year":"1995","unstructured":"Rinder CS, Rinder HM, Smith BR, Fitch JCK, Smith MJ, Tracey JB, et al. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. Clin Invest. 1995;96:1564\u201372.","journal-title":"Clin Invest"},{"issue":"9665","key":"1314_CR32","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(09)60001-5","volume":"373","author":"C Parker","year":"2009","unstructured":"Parker C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet. 2009;373(9665):759\u201367.","journal-title":"Lancet"},{"issue":"2","key":"1314_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/jir.1991.11.69","volume":"11","author":"JB Klein","year":"1991","unstructured":"Klein JB, Scherzer JA, McLeish KR. Interferon-gamma enhances superoxide production by HL-60 cells stimulated with multiple agonists. J Interf Res. 1991;11(2):69\u201374.","journal-title":"J Interf Res"},{"issue":"2","key":"1314_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.intimp.2013.12.010","volume":"18","author":"LF Marchi","year":"2014","unstructured":"Marchi LF, Sesti-Costa R, Ignacchiti MDC, Chedraoui-Silva S, Mantovani B. In vitro activation of mouse neutrophils by recombinant human interferon-gamma: increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines. Int Immunopharmacol. Elsevier B.V. 2014;18(2):228\u201335.","journal-title":"Int Immunopharmacol"},{"key":"1314_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-1759(84)90432-0","volume":"72","author":"UR Nilsson","year":"1984","unstructured":"Nilsson UR, Nilsson B. Simplified assays of hemolytic activity of the classical and alternative complement pathways. J lmmunol Methods. 1984;72:49\u201359.","journal-title":"J lmmunol Methods"},{"issue":"3","key":"1314_CR36","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1128\/JCM.01654-09","volume":"48","author":"T Hallstr\u00f6m","year":"2010","unstructured":"Hallstr\u00f6m T, Resman F, Ristovski M, Riesbeck K. Binding of complement regulators to invasive nontypeable Haemophilus influenzae isolates is not increased compared to nasopharyngeal isolates, but serum resistance is linked to disease severity. J Clin Microbiol. 2010;48(3):921\u20137.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1314_CR37","doi-asserted-by":"publisher","first-page":"e00079","DOI":"10.1128\/mBio.00079-12","volume":"3","author":"JD Langereis","year":"2012","unstructured":"Langereis JD, Stol K, Schweda EK, Twelkmeyer B, Bootsma HJ, de Vries SPW, et al. Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media. MBio. 2012;3(4):e00079\u201312.","journal-title":"MBio"},{"issue":"2","key":"1314_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijmm.2017.01.005","volume":"307","author":"S Lichtenegger","year":"2017","unstructured":"Lichtenegger S, Bina I, Durakovic S, Glaser P, Tutz S, Schild S, et al. Serum resistance and phase variation of a nasopharyngeal non-typeable Haemophilus influenzae isolate. Int J Med Microbiol. 2017;307(2):139\u201346.","journal-title":"Int J Med Microbiol"},{"issue":"1","key":"1314_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/mmi.12741","volume":"94","author":"JD Langereis","year":"2014","unstructured":"Langereis JD, de Jonge MI, Weiser JN. Binding of human factor H to outer membrane protein P5 of non-typeable Haemophilus influenzae contributes to complement resistance. Mol Microbiol. 2014;94(1):89\u2013106.","journal-title":"Mol Microbiol"},{"issue":"3","key":"1314_CR40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CDLI.8.3.616-623.2001","volume":"8","author":"GF Santos","year":"2001","unstructured":"Santos GF, Deck RR, Donnelly J, Blackwelder W, Granoff DM. Importance of complement source in measuring meningococcal bactericidal titers. Clin Diagn Lab Immunol American Society for Microbiology (ASM). 2001;8(3):616\u201323.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"1314_CR41","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1574-695X.2012.00967.x","volume":"65","author":"MN Khan","year":"2012","unstructured":"Khan MN, Kaur R, Pichichero ME. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children. FEMS Immunol Med Microbiol. 2012;65(3):439\u201347.","journal-title":"FEMS Immunol Med Microbiol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-018-1314-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12866-018-1314-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-018-1314-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T06:58:41Z","timestamp":1605337121000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-018-1314-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1186\/s12866-018-1314-5","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"19 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All laboratory staff at Public Health England, Porton Down that donated blood signed an informed consent form. All samples were anonymised. The consent form used for the collection of blood, to be used as anonymised reagents or controls for assay development, did not require approval by an external ethics committee, which is in compliance with revised guidance Governance Arrangements for UK Research Ethics Committees (GAfREC) (September 2011). The blood collection consent form has been through internal review at Public Health England to ensure it is fully compliant with all current regulations including the NHS Research Governance Framework for Health and Social Care (April 2005), the World Medical Association Declaration of Helsinki (1996), the Human Tissue Act (2004) and the Data Protection Act (1998).The study carried out at University Southampton Faculty of Medicine (ClinicalTrials.gov: NCT01701869) was performed in accordance with the Declaration of Helsinki and was approved by the National Research Ethics Service (NRES) Southampton B Committee (12\/SC\/0304). All subjects gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have declared the following interests: PL and DW are employees of the GSK group of companies. PL reports ownership of shares and\/or restricted shares in the GSK group of companies. The other authors report no financial competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"167"}}